There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Privia Health Group (PRVA – Research Report), Revance Therapeutics (RVNC – Research Report) and Quantum-Si (QSI – Research Report) with bullish sentiments.
Privia Health Group (PRVA)
In a report released yesterday, Sean Dodge from RBC Capital maintained a Buy rating on Privia Health Group, with a price target of $28.00. The company’s shares closed last Thursday at $18.03, close to its 52-week low of $16.90.
According to TipRanks.com, Dodge is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Privia Health Group is a Strong Buy with an average price target of $26.93, implying a 45.7% upside from current levels. In a report issued on May 2, Stifel Nicolaus also maintained a Buy rating on the stock with a $24.00 price target.
See today’s best-performing stocks on TipRanks >>
Revance Therapeutics (RVNC)
Needham analyst Serge Belanger maintained a Buy rating on Revance Therapeutics today and set a price target of $12.00. The company’s shares closed last Thursday at $4.29, close to its 52-week low of $3.21.
According to TipRanks.com, Belanger is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Revance Therapeutics with a $15.78 average price target, representing a 266.1% upside. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $11.00 price target.
Quantum-Si (QSI)
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Quantum-Si today and set a price target of $4.00. The company’s shares closed last Thursday at $1.83.
According to TipRanks.com, Ramakanth is a 4-star analyst with an average return of
Quantum-Si has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PRVA:
